BACKGROUND: Tumor necrosis factor-like weak inducer of apoptosis (TWEAK), a member of the tumor necrosis factor superfamily, is a multifunctional cytokine known to regulate cellular functions in contexts of injury and disease through its receptor, fibroblast growth factor-inducible molecule 14 (Fn14). Although many of the processes and downstream signals regulated by the TWEAK/Fn14 pathway have been implicated in the development of cardiac dysfunction, the role of TWEAK in the cardiovascular system is completely unknown. METHODS AND RESULTS: Herein, we demonstrate that mouse and human cardiomyocytes express the TWEAK receptor Fn14. Furthermore, we determine that elevated circulating levels of TWEAK, induced via transgenic or adenoviral-mediated gene expression in mice, result in dilated cardiomyopathy with subsequent severe cardiac dysfunction. This phenotype was mediated exclusively by the Fn14 receptor, independent of tumor necrosis factor-alpha, and was associated with cardiomyocyte elongation and cardiac fibrosis but not cardiomyocyte apoptosis. Moreover, we find that circulating TWEAK levels were differentially upregulated in patients with idiopathic dilated cardiomyopathy compared with other forms of heart disease and normal control subjects. CONCLUSIONS: Our data suggest that TWEAK/Fn14 may be important in regulating myocardial structural remodeling and function and may play a role in the pathogenesis of dilated cardiomyopathy.
BACKGROUND:Tumor necrosis factor-like weak inducer of apoptosis (TWEAK), a member of the tumor necrosis factor superfamily, is a multifunctional cytokine known to regulate cellular functions in contexts of injury and disease through its receptor, fibroblast growth factor-inducible molecule 14 (Fn14). Although many of the processes and downstream signals regulated by the TWEAK/Fn14 pathway have been implicated in the development of cardiac dysfunction, the role of TWEAK in the cardiovascular system is completely unknown. METHODS AND RESULTS: Herein, we demonstrate that mouse and human cardiomyocytes express the TWEAK receptorFn14. Furthermore, we determine that elevated circulating levels of TWEAK, induced via transgenic or adenoviral-mediated gene expression in mice, result in dilated cardiomyopathy with subsequent severe cardiac dysfunction. This phenotype was mediated exclusively by the Fn14 receptor, independent of tumor necrosis factor-alpha, and was associated with cardiomyocyte elongation and cardiac fibrosis but not cardiomyocyte apoptosis. Moreover, we find that circulating TWEAK levels were differentially upregulated in patients with idiopathic dilated cardiomyopathy compared with other forms of heart disease and normal control subjects. CONCLUSIONS: Our data suggest that TWEAK/Fn14 may be important in regulating myocardial structural remodeling and function and may play a role in the pathogenesis of dilated cardiomyopathy.
Authors: Andrew I Su; Michael P Cooke; Keith A Ching; Yaron Hakak; John R Walker; Tim Wiltshire; Anthony P Orth; Raquel G Vega; Lisa M Sapinoso; Aziz Moqrich; Ardem Patapoutian; Garret M Hampton; Peter G Schultz; John B Hogenesch Journal: Proc Natl Acad Sci U S A Date: 2002-03-19 Impact factor: 11.205
Authors: S R Wiley; L Cassiano; T Lofton; T Davis-Smith; J A Winkles; V Lindner; H Liu; T O Daniel; C A Smith; W C Fanslow Journal: Immunity Date: 2001-11 Impact factor: 31.745
Authors: R L Meighan-Mantha; D K Hsu; Y Guo; S A Brown; S L Feng; K A Peifley; G F Alberts; N G Copeland; D J Gilbert; N A Jenkins; C M Richards; J A Winkles Journal: J Biol Chem Date: 1999-11-12 Impact factor: 5.157
Authors: Sean Campbell; Linda C Burkly; Hua-Xin Gao; Joan W Berman; Lihe Su; Beth Browning; Timothy Zheng; Lena Schiffer; Jennifer S Michaelson; Chaim Putterman Journal: J Immunol Date: 2006-02-01 Impact factor: 5.422
Authors: S L Feng; Y Guo; V M Factor; S S Thorgeirsson; D W Bell; J R Testa; K A Peifley; J A Winkles Journal: Am J Pathol Date: 2000-04 Impact factor: 4.307
Authors: Juan J Carrero; Alberto Ortiz; Abdul R Qureshi; Jose L Martín-Ventura; Peter Bárány; Olof Heimbürger; Belén Marrón; George Metry; Sunna Snaedal; Bengt Lindholm; Jesús Egido; Peter Stenvinkel; Luis M Blanco-Colio Journal: Clin J Am Soc Nephrol Date: 2008-10-22 Impact factor: 8.237
Authors: Fernando L Martin; Paul M McKie; Alessandro Cataliotti; S Jeson Sangaralingham; Josef Korinek; Brenda K Huntley; Elise A Oehler; Gerald E Harders; Tomoko Ichiki; Sarah Mangiafico; Karl A Nath; Margaret M Redfield; Horng H Chen; John C Burnett Journal: Am J Physiol Regul Integr Comp Physiol Date: 2011-11-09 Impact factor: 3.619
Authors: Sathya D Unudurthi; Drew M Nassal; Nehal J Patel; Evelyn Thomas; Jane Yu; Curtis G Pierson; Shyam S Bansal; Peter J Mohler; Thomas J Hund Journal: Life Sci Date: 2020-02-15 Impact factor: 5.037
Authors: Harshil Dhruv; Joseph C Loftus; Pooja Narang; Joachim L Petit; Maureen Fameree; Julien Burton; Giresse Tchegho; Donald Chow; Holly Yin; Yousef Al-Abed; Michael E Berens; Nhan L Tran; Nathalie Meurice Journal: J Biol Chem Date: 2013-09-20 Impact factor: 5.157
Authors: Vijay G Divakaran; Sarah Evans; Veli K Topkara; Abhinav Diwan; Jana Burchfield; Feng Gao; Jianwen Dong; Huei-Ping Tzeng; Natarajan Sivasubramanian; Philip M Barger; Douglas L Mann Journal: Circ Heart Fail Date: 2013-03-14 Impact factor: 8.790